Glycoprotein-340 polyclonal, anti-human, mouse, rat
€422.00
In stock
SKU
251237
Catalog Nr.: 251237
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Datasheet
Request Information
Size: 0.1 mg
Isotype: Rabbit Ig
Applications: E, WB, IHC
Datasheet
Request Information
Protein Family: Chaperones and Folding Catalysts
Pathway and Disease: Signaling Molecules and Interaction, Cancers, Immune System
Description:
Deleted in malignant brain tumors 1 protein (glycoprotein-340), a secreted glycoprotein, is considered a candidate tumor suppressor gene for brain, lung, esophageal, gastric, and colorectal cancers. Glycoprotein-340 plays roles in mucosal defense system, cellular immune defense and epithelial differentiation. Defects in glycoprotein-340 are involved in the development of glioma (GLM). Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas.
Alternate Names: Deleted in malignant brain tumors 1 protein, Glycoprotein 340, Gp-340, Surfactant pulmonary-associated D-binding protein, Hensin, DMBT1, GP340, Salivary agglutin, SAG
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500; IP: 1:100-1:500
Accession No.: Q9UGM3
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human glycoprotein-340.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 25% glycerol, 1 mg/ml BSA with 0.09% sodium azide. Antibody was purified by Protein-A affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
Pathway and Disease: Signaling Molecules and Interaction, Cancers, Immune System
Description:
Deleted in malignant brain tumors 1 protein (glycoprotein-340), a secreted glycoprotein, is considered a candidate tumor suppressor gene for brain, lung, esophageal, gastric, and colorectal cancers. Glycoprotein-340 plays roles in mucosal defense system, cellular immune defense and epithelial differentiation. Defects in glycoprotein-340 are involved in the development of glioma (GLM). Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas.
Alternate Names: Deleted in malignant brain tumors 1 protein, Glycoprotein 340, Gp-340, Surfactant pulmonary-associated D-binding protein, Hensin, DMBT1, GP340, Salivary agglutin, SAG
Application Notes: E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500; IP: 1:100-1:500
Accession No.: Q9UGM3
Antigen: KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human glycoprotein-340.
Format: Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 25% glycerol, 1 mg/ml BSA with 0.09% sodium azide. Antibody was purified by Protein-A affinity chromatography.
Storage:
Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.
| Is Featured? | No |
|---|
Write Your Own Review